Recent research into retatruptide peptide highlight significant potential for treating obesity and non-insulin dependent diabetes. The compound, a dual stimulator of GLP-1 receptor and GIP, appears to offer greater weight reduction and blood sugar management in contrast to existing treatments. Fu